Volume 111, Issue 1

Search all International Journal of Hematology articles

January 2020

Including PIH articles on Current progress and future direction in the treatment for haemophilia

Filter by

Volume:

Sort by

Date published:

New to old Old to new

21 articles in this issue

Mastocytosis by minor criteria
Eric McGinnis
Habib Moshref Razavi
Images in Hematology 08 November 2019 Pages: 1 - 2
Mature neutrophils with Auer rod bundles in CBFB-MYH11-positive acute myeloid leukemia
Nicolas Duployez
Claire Bories
Images in Hematology 12 November 2019 Pages: 3 - 4
JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-4. Mantle cell lymphoma (MCL)
Masataka Okamoto
Shigeru Kusumoto
Guideline 10 December 2019 Pages: 5 - 15
Current progress and future direction in the treatment for hemophilia
Midori Shima
Progress in Hematology 07 December 2019 Pages: 16 - 19
Emicizumab, a humanized bispecific antibody to coagulation factors IXa and X with a factor VIIIa-cofactor activity
Takehisa Kitazawa
Midori Shima
Progress in Hematology 22 October 2018 Pages: 20 - 30
Advances in gene therapy for hemophilia: basis, current status, and future perspectives
Tsukasa Ohmori
Progress in Hematology 06 August 2018 Pages: 31 - 41
Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia
Pratima Chowdary
Progress in Hematology 09 October 2018 Pages: 42 - 50
Genetic analysis of a compound heterozygous patient with congenital factor X deficiency and regular replacement therapy with a prothrombin complex concentrate
Tomoki Togashi
Satomi Nagaya
Eriko Morishita
Original Article 30 October 2019 Pages: 51 - 56
Final results of a phase I study of carfilzomib, lenalidomide, and dexamethasone for heavily pretreated multiple myeloma
Isamu Sugiura
Kenshi Suzuki
Shinsuke Iida
Original Article 29 October 2019 Pages: 57 - 64
Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan
Kohmei Kubo
Mitsuo Hori
Naoki Takezako
Original Article 07 November 2019 Pages: 65 - 74
Recurrent intragenic exon rearrangements of SOBP and AUTS2 in non-Hodgkin B-cell lymphoma
Yosuke Matsumoto
Yoshiaki Chinen
Masafumi Taniwaki
Original Article 04 November 2019 Pages: 75 - 83
Analysis of glutathione S-transferase and cytochrome P450 gene polymorphism in recipients of dose-adjusted busulfan-cyclophosphamide conditioning
Seitaro Terakura
Makoto Onizuka
The Nagoya Blood and Marrow Transplantation Group
Original Article 25 September 2019 Pages: 84 - 92
Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan
Masamitsu Yanada
Akiyoshi Takami
Shingo Yano
Original Article 14 October 2019 Pages: 93 - 102
Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis
Kazuhito Suzuki
Nobuhiro Tsukada
Kenshi Suzuki
Original Article 30 October 2019 Pages: 103 - 111
Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantation
Sonoko Kamoshita
Makoto Murata
Hitoshi Kiyoi
Original Article 26 September 2019 Pages: 112 - 119
Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation
Ayumu Ito
Shigehisa Kitano
Shinichiro Okamoto
Original Article 22 October 2019 Pages: 120 - 130
Prognostic factors for survival of herpes simplex virus-associated hemophagocytic lymphohistiocytosis
Motoshi Sonoda
Masataka Ishimura
Shouichi Ohga
Original Article 23 September 2019 Pages: 131 - 136
Nationwide retrospective review of hematopoietic stem cell transplantation in children with refractory Langerhans cell histiocytosis
Kazuko Kudo
Miho Maeda
The Histiocytosis study group of the Japanese Society of Pediatric Hematology/Oncology
Original Article 22 November 2019 Pages: 137 - 148
Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D−− phenotype
Kazuya Mimura
Masayuki Endo
Tadashi Kimura
Case Report 19 September 2019 Pages: 149 - 154
2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome
Yasufumi Masaki
Hiroshi Kawabata
Japanese TAFRO Syndrome Research Team
Letter to the Editor 28 November 2019 Pages: 155 - 158
Correction to: Analysis of glutathione S-transferase and cytochrome P450 gene polymorphism in recipients of dose-adjusted busulfan-cyclophosphamide conditioning
Seitaro Terakura
Makoto Onizuka
The Nagoya Blood and Marrow Transplantation Group
Correction 26 November 2019 Pages: 159 - 160

Volume 111, Issue 1

Mastocytosis by minor criteria

Mature neutrophils with Auer rod bundles in CBFB-MYH11-positive acute myeloid leukemia

JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-4. Mantle cell lymphoma (MCL)

Current progress and future direction in the treatment for hemophilia

Emicizumab, a humanized bispecific antibody to coagulation factors IXa and X with a factor VIIIa-cofactor activity

Advances in gene therapy for hemophilia: basis, current status, and future perspectives

Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia

Genetic analysis of a compound heterozygous patient with congenital factor X deficiency and regular replacement therapy with a prothrombin complex concentrate

Final results of a phase I study of carfilzomib, lenalidomide, and dexamethasone for heavily pretreated multiple myeloma

Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan

Recurrent intragenic exon rearrangements of SOBP and AUTS2 in non-Hodgkin B-cell lymphoma

Analysis of glutathione S-transferase and cytochrome P450 gene polymorphism in recipients of dose-adjusted busulfan-cyclophosphamide conditioning

Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan

Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis

Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantation

Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation

Prognostic factors for survival of herpes simplex virus-associated hemophagocytic lymphohistiocytosis

Nationwide retrospective review of hematopoietic stem cell transplantation in children with refractory Langerhans cell histiocytosis

Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D−− phenotype

2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome

Correction to: Analysis of glutathione S-transferase and cytochrome P450 gene polymorphism in recipients of dose-adjusted busulfan-cyclophosphamide conditioning

Navigation